We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Amarna Therapeutics, a privately held biotechnology company, has appointed Steen Klysner, Ph.D. as its new chief executive officer as per September 1. Founder and CEO Ben van Leent will become a member of Amarna's Supervisory Board.